Stellate ganglion block, a nerve block injection originally developed for pain conditions, has shown genuine promise for reducing certain PTSD symptoms, but the clinical trial evidence is surprisingly mixed. The strongest randomized controlled trial found about twice the symptom improvement compared to a sham injection, while another well-designed trial found no meaningful difference at all. The picture gets more interesting when you look at which specific symptoms respond and what happens when the block is combined with psychotherapy.
What the Procedure Actually Involves
The stellate ganglion is a bundle of nerve cells in the neck, on either side of the voice box, that serves as a hub for the body’s sympathetic nervous system. That’s the system responsible for the “fight or flight” response. In PTSD, the sympathetic nervous system appears to be stuck in overdrive, keeping the brain’s threat-detection circuitry on high alert even when no danger is present. This is thought to stem from disrupted communication among brain regions involved in processing threats and emotional memories.
During a stellate ganglion block, a doctor uses ultrasound or fluoroscopy to guide a needle to the nerve cluster and injects a local anesthetic, typically on the right side of the neck. The whole thing takes about fifteen minutes. The idea is that temporarily numbing this nerve relay point can reset the sympathetic nervous system’s overactivity, essentially turning down the volume on the body’s alarm system. The anesthetic itself wears off within hours, but the calming effect on PTSD symptoms appears to outlast the drug by weeks or months.
What the Randomized Trials Show
The strongest evidence in favor comes from a sham-controlled trial published in JAMA Psychiatry. Active-duty military members with PTSD received either two real stellate ganglion blocks or two sham injections, spaced two weeks apart. Over eight weeks, the group that received real blocks saw their clinician-rated symptom scores drop by an average of about 13 points, compared to roughly 6 points in the sham group. That’s a statistically and clinically meaningful gap, roughly double the improvement from placebo alone.1JAMA Psychiatry. Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial
But a second randomized trial, also double-blinded, told a different story. In that study, PTSD, anxiety, and depression scores improved over time in both the real-block and sham groups, with no meaningful difference between them. Participants who initially received the sham and then crossed over to receive a real block showed no additional benefit from the switch. The researchers concluded that current evidence does not support widespread clinical use of the procedure for PTSD.2Regional Anesthesia & Pain Medicine. Stellate Ganglion Block for the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Controlled Trial
A systematic review of the broader research landscape confirmed this split. Of the two randomized controlled trials available at the time of review, one showed significant improvement while the other did not.3PubMed Central. Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape That’s a frustrating result for anyone hoping for a clear answer, and it means the evidence base is still genuinely in tension. Differences in the patient populations, injection technique, timing of follow-up, and the specific anesthetics used may account for the discrepancy, but nobody has pinned down exactly why one trial worked and the other didn’t.
Hyperarousal Responds Best, Re-Experiencing the Least
PTSD is not a single monolithic experience. Clinicians recognize distinct symptom clusters: intrusive re-experiencing of the trauma (flashbacks, nightmares), avoidance behaviors, negative changes in mood and thinking, and hyperarousal (being constantly on edge, startling easily, poor sleep, trouble concentrating). Across multiple studies, the hyperarousal cluster consistently shows the largest response to stellate ganglion block, while re-experiencing symptoms tend to improve the least.4PubMed Central. Stellate Ganglion Block for Post-traumatic Stress Disorder: A Comprehensive Review of Evidence, Technique Considerations and Symptom Outcomes in Military and Non-Military Patients
A secondary analysis of the positive JAMA Psychiatry trial drilled deeper into these differences. The arousal and reactivity cluster showed the greatest reductions after the block compared to sham. When researchers examined individual symptoms, the strongest drivers were reductions in hypervigilance, concentration difficulties, and sleep disturbance. For clinician-rated outcomes, the re-experiencing cluster also showed pronounced improvement, but those gains were driven by specific items like reduced physiological and emotional reactions to trauma cues and fewer intrusive thoughts, rather than across-the-board improvement. Self-reported re-experiencing did not show the same pattern.5Translational Psychiatry. Differential posttraumatic stress disorder symptom cluster response to stellate ganglion block: secondary analysis of a randomized controlled trial
This matters practically. If your PTSD is dominated by being on edge all the time, sleeping badly, and jumping at every noise, the block may offer meaningful relief. If your primary burden is intrusive memories and flashbacks, the evidence is less encouraging, at least for the block working alone. The mechanism makes intuitive sense: the stellate ganglion is a sympathetic nervous system relay, so calming it down would logically do more for the body’s physical arousal response than for the cognitive and emotional content of trauma memories.
Combining the Block with Psychotherapy
One of the more interesting directions in this space is using stellate ganglion block not as a standalone treatment but as a way to make trauma-focused therapy work better. The logic is straightforward: many people with PTSD avoid or drop out of evidence-based therapies like prolonged exposure or cognitive processing therapy because the treatments require deliberately confronting traumatic memories, which can spike anxiety to intolerable levels. If the block can dampen that physiological reactivity, patients might be able to engage more deeply with therapy.
A nonrandomized clinical trial tested this by combining stellate ganglion blocks with prolonged exposure therapy. Participants reported an average reduction of 32 points on a standard PTSD symptom checklist, which is a large drop. About 91% showed clinically meaningful change by the final treatment session, and half no longer met diagnostic criteria for PTSD at a one-month follow-up.6PubMed. Combining a stellate ganglion block with prolonged exposure therapy for posttraumatic stress disorder: A nonrandomized clinical trial Those numbers are striking, though the lack of a control group means we can’t separate the block’s contribution from the therapy alone.
A pilot study in combat veterans similarly paired stellate ganglion block with in vivo exposure exercises and found significant decreases in PTSD symptoms on both self-report and clinician-rated measures. The researchers noted that the combination appeared feasible and acceptable to veterans, a population often reluctant to engage with traditional mental health treatment.7PubMed. A pilot study of stellate ganglion block paired with exposure therapy: Feasibility and acceptability in combat veterans with posttraumatic stress disorder
However, a pilot randomized trial that paired the block with an accelerated form of cognitive processing therapy tempered that enthusiasm. Both the block-plus-therapy and the placebo-plus-therapy groups experienced large improvements in PTSD and depression symptoms, but there was no significant difference between them over three months. One notable finding: the group that received the real block had lower self-reported symptoms on the first day of therapy, suggesting the block may ease early engagement even if it doesn’t change the final outcome.8Journal of Traumatic Stress. Enhancing cognitive processing therapy via stellate ganglion blocks: A pilot randomized trial The pattern echoes the standalone evidence: promising signals in open-label and nonrandomized work that partly dissolve once a proper control group enters the picture.
How Long Relief Lasts
When the block does work, how long can you expect the benefit to last? Across available studies, the effects appear to persist for roughly three to six months before symptoms begin to return.4PubMed Central. Stellate Ganglion Block for Post-traumatic Stress Disorder: A Comprehensive Review of Evidence, Technique Considerations and Symptom Outcomes in Military and Non-Military Patients That’s considerably longer than the few hours the anesthetic itself remains active, which supports the theory that the block triggers some kind of reset in sympathetic tone rather than just providing temporary numbing.
Repeat injections appear to be both safe and effective when the initial block wears off. Some protocols call for two injections spaced a couple of weeks apart as a standard course, and the negative RCT actually noted that improvement on clinician-rated scales was greater after the second block than after the first.2Regional Anesthesia & Pain Medicine. Stellate Ganglion Block for the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Controlled Trial This raises the possibility that some patients may need a series of injections before seeing results, and that one-shot trials might underestimate the treatment’s potential.
The question of who needs ongoing repeat blocks and who sees lasting remission after a single course hasn’t been well studied. This is one of the bigger gaps in the research. Without long-term follow-up data beyond a few months, it’s hard to say whether the block offers a durable reset or a temporary reprieve that needs periodic renewal.
Safety and Side Effects
The stellate ganglion block has been used for pain conditions since the early twentieth century, so clinicians have significant experience with the procedure. A systematic review of complications across all indications found that the majority of adverse events were related to the medication or systemic effects, reported in about two-thirds of cases in the review, while roughly a third were local or procedure-related complications.9PubMed Central. Complications associated with stellate ganglion nerve block: a systematic review
The most common side effect is Horner’s syndrome, which causes a drooping eyelid, constricted pupil, and reduced sweating on the side of the injection. This is actually expected and temporary: it confirms the block reached the right nerve cluster and resolves on its own within hours. Other known complications include temporary hoarseness from affecting the recurrent laryngeal nerve, numbness in the arm from unintended spread to the brachial plexus, and, rarely, pneumothorax.10Korean Journal of Anesthesiology. Bilateral Horner’s Syndrome after a Stellate Ganglion Block
Serious complications are rare but not zero. The same systematic review documented one death from a massive hematoma that obstructed the airway, and one case of quadriplegia from a spinal infection following the procedure.9PubMed Central. Complications associated with stellate ganglion nerve block: a systematic review These are across all uses of the block, not specifically PTSD patients, and they represent extreme outliers. The introduction of ultrasound guidance has improved the precision of needle placement, which should reduce, though not eliminate, the risk of hitting unintended structures. Most adverse events occurred during or shortly after the injection, meaning patients can be monitored in the clinic for the brief window of highest risk.
Who Might Benefit Most
The available evidence suggests the block works across both military and civilian populations and across different types of trauma.4PubMed Central. Stellate Ganglion Block for Post-traumatic Stress Disorder: A Comprehensive Review of Evidence, Technique Considerations and Symptom Outcomes in Military and Non-Military Patients Most of the published trials have focused on military populations, which reflects both where the early interest came from and which institutions had the infrastructure to conduct the studies. Whether the results generalize fully to civilian trauma survivors remains an open question, though there’s no strong biological reason to expect the nerve block would behave differently depending on how the PTSD was acquired.
Severity may matter. One comprehensive review noted that both mild-to-moderate and severe cases showed positive effects, but severe cases may benefit more.4PubMed Central. Stellate Ganglion Block for Post-traumatic Stress Disorder: A Comprehensive Review of Evidence, Technique Considerations and Symptom Outcomes in Military and Non-Military Patients This makes some conceptual sense. People with severe hyperarousal have the most room for the sympathetic nervous system to be dialed back. Someone whose PTSD symptoms are milder or dominated by avoidance and cognitive symptoms may see less obvious benefit from a procedure that primarily targets physiological arousal.
The treatment has drawn particular interest among military populations partly because of the well-documented reluctance of service members and veterans to pursue traditional mental health care. A literature review noted that the block may help reduce barriers to therapy in this group.11PubMed. Stellate Ganglion Block in the Treatment of Post-traumatic Stress Disorder: A Review of Historical and Recent Literature Getting a shot in the neck feels more like a medical procedure than sitting in a therapist’s office, which matters for people who avoid anything framed as mental health treatment. Whether that framing advantage translates into better long-term outcomes is unclear, but getting someone into the treatment pipeline at all is half the battle.
Where Clinical Guidelines Stand
Despite the pockets of promising data, stellate ganglion block has not been formally endorsed by major clinical practice guidelines for PTSD. A Canadian health technology assessment found that guideline authors were unable to recommend for or against the procedure due to insufficient evidence.12Canadian Journal of Health Technologies. Stellate Ganglion Block for the Treatment of Post-Traumatic Stress Disorder, Depression, and Anxiety That’s a significant distinction: “we can’t recommend it yet” is different from “we recommend against it.” The door is open, but the evidence hasn’t crossed the threshold most guideline committees require.
The U.S. Department of Defense and Veterans Affairs have taken a more cautious stance than some individual military treatment facilities, where the block is offered more readily. This creates a somewhat confusing landscape where you might be able to get the procedure at certain military hospitals or private pain clinics while the official guidelines remain noncommittal. Insurance coverage is inconsistent as well, since many payers will cover stellate ganglion block for its established pain indications but may not cover it for PTSD specifically.
The core issue is sample size. The positive JAMA Psychiatry trial enrolled just over 100 participants, which is respectable for this kind of study but far smaller than the trials that typically drive guideline changes. The negative trial was even smaller. Until larger, multi-site randomized trials confirm or deny the benefit, the procedure will likely remain in a gray area: too promising to dismiss, too thinly supported to recommend broadly.
The Placebo Problem
One of the trickiest aspects of interpreting this research is the unusually strong placebo response. In both the positive and negative randomized trials, the sham groups improved substantially. Getting an injection in the neck is a dramatic physical experience. The clinical setting, the attention from specialists, the expectation that something is being done: all of these are powerful placebo amplifiers. In the negative trial, the sham group improved on PTSD, anxiety, and depression scores to a degree that essentially matched the real-block group.2Regional Anesthesia & Pain Medicine. Stellate Ganglion Block for the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Controlled Trial
This doesn’t mean the improvement is “fake.” People who feel better after a sham injection genuinely feel better. Their stress hormones drop, their sleep can improve, their avoidance behaviors may ease. But it does mean that separating the specific pharmacological effect of numbing the stellate ganglion from the nonspecific effects of the medical encounter is genuinely difficult. Future trials will need to be large enough to detect relatively modest effects above and beyond what the placebo response provides, and those trials are expensive and logistically challenging to run.
The field is also grappling with a measurement challenge. The clinician-rated PTSD scale and the self-report checklist don’t always agree, as the symptom-cluster analysis showed. Clinicians detected improvements in re-experiencing that patients didn’t report themselves.5Translational Psychiatry. Differential posttraumatic stress disorder symptom cluster response to stellate ganglion block: secondary analysis of a randomized controlled trial That discrepancy makes it harder to design trials with clear, unambiguous endpoints and adds another layer of uncertainty to the whole enterprise.